T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells

被引:396
作者
Fahlén, L
Read, S
Gorelik, L
Hurst, SD
Coffman, RL
Flavell, RA
Powrie, F
机构
[1] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
[2] Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA
[3] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA
[4] Dynavax Technol Corp, Albany, CA 94710 USA
基金
英国惠康基金;
关键词
D O I
10.1084/jem.20040685
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4(+)CD25(+) regulatory T (T reg) cells play a pivotal role in control of the immune response. Transforming growth factor-beta (TGF-beta) has been shown to be required for T reg cell activity; however, precisely how it is involved in the mechanism of suppression is poorly understood. Using the T cell transfer model of colitis, we show here that CD4(+)CD45RB(high) T cells that express a dominant negative TGF-beta receptor type II (dnT beta RII) and therefore cannot respond to TGF-beta, escape control by T reg cells in vivo. CD4(+)CD25(+) T reg cells from the thymus of dnT beta RII mice retain the ability to inhibit colitis, suggesting that T cell responsiveness to TGF-beta is not required for the development or peripheral function of thymic-derived T reg cells. In contrast, T reg cell activity among the peripheral dnT beta RII CD4(+)CD25(+) population is masked by the presence of colitogenic effector cells that cannot be suppressed. Finally, we show that CD4(+)CD25(+) T reg cells develop normally in the absence of TGF-beta 1 and retain the ability to suppress colitis in vivo. Importantly, the function of TGF-beta 1(-/-) T reg cells was abrogated by anti-TGF-beta monoclonal antibody, indicating that functional TGF-beta can be provided by a non-T reg cell source.
引用
收藏
页码:737 / 746
页数:10
相关论文
共 49 条
[1]   An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation [J].
Asseman, C ;
Mauze, S ;
Leach, MW ;
Coffman, RL ;
Powrie, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :995-1003
[2]   Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice:: Control by CD4+ regulatory T cells and IL-10 [J].
Asseman, C ;
Read, S ;
Powrie, F .
JOURNAL OF IMMUNOLOGY, 2003, 171 (02) :971-978
[3]   TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes [J].
Belghith, M ;
Bluestone, JA ;
Barriot, S ;
Mégret, J ;
Bach, JF ;
Chatenoud, L .
NATURE MEDICINE, 2003, 9 (09) :1202-1208
[4]   CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity [J].
Belkaid, Y ;
Piccirillo, CA ;
Mendez, S ;
Shevach, EM ;
Sacks, DL .
NATURE, 2002, 420 (6915) :502-507
[5]   Transforming growth factor β blocks Tec kinase phosphorylation, Ca2+ influx, and NFATc translocation causing inhibition of T cell differentiation [J].
Chen, CH ;
Seguin-Devaux, C ;
Burke, NA ;
Oriss, TB ;
Watkins, SC ;
Clipstone, N ;
Ray, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (12) :1689-1699
[6]   Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3 [J].
Chen, WJ ;
Jin, WW ;
Hardegen, N ;
Lei, KJ ;
Li, L ;
Marinos, N ;
McGrady, G ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1875-1886
[7]   Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants [J].
Cobbold, SP ;
Castejon, R ;
Adams, E ;
Zelenika, D ;
Graca, L ;
Humm, S ;
Waldmann, H .
JOURNAL OF IMMUNOLOGY, 2004, 172 (10) :6003-6010
[8]   THERAPY WITH MONOCLONAL-ANTIBODIES BY ELIMINATION OF T-CELL SUBSETS INVIVO [J].
COBBOLD, SP ;
JAYASURIYA, A ;
NASH, A ;
PROSPERO, TD ;
WALDMANN, H .
NATURE, 1984, 312 (5994) :548-551
[9]  
Coffman R L, 1982, Immunol Rev, V69, P5
[10]   Thrombospondin-1 is a major activator of TGF-β1 in vivo [J].
Crawford, SE ;
Stellmach, V ;
Murphy-Ullrich, JE ;
Ribeiro, SMF ;
Lawler, J ;
Hynes, RO ;
Boivin, GP ;
Bouck, N .
CELL, 1998, 93 (07) :1159-1170